Author： Feinglass Joe Adams Jared R Djubegovic Benjamin Bennett Charles L Lyman Gary H
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.9, 2002-09, pp. : 1273-1281
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
G-CSF reduces febrile neutropenia and mortality risk
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
Access to resources
Recommend
New G-CSF agonists for neutropenia therapy
By Hoggatt Jonathan Pelus Louis M
Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. :
G-CSF prophylaxis: when second comes first
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 650, 2012-01 ,pp. :
Pegfilgrastim fits the bill for febrile neutropenia prophylaxis in Europe
Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. :
Pegfilgrastim fits the bill for febrile neutropenia prophylaxis in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. :